Straumann (OTCMKTS: SAUHY) recently received a number of ratings updates from brokerages and research firms:
- 7/9/2026 – Straumann had its “sell” rating reaffirmed by Citigroup Inc..
- 7/8/2026 – Straumann is now covered by BMO Capital Markets. They set an “outperform” rating on the stock.
- 6/30/2026 – Straumann had its “underweight” rating reaffirmed by Morgan Stanley.
- 6/30/2026 – Straumann had its “buy” rating reaffirmed by Deutsche Bank Aktiengesellschaft.
- 6/18/2026 – Straumann had its “overweight” rating reaffirmed by Barclays PLC.
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
See Also
- Five stocks we like better than Straumann
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
- Amazon’s AI Spending Is About to Face Its Most Important AWS Test Yet
Receive News & Ratings for Straumann Holding AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann Holding AG and related companies with MarketBeat.com's FREE daily email newsletter.
